ארזרה 1000 מ"ג ישראל - עברית - Ministry of Health

ארזרה 1000 מ"ג

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

ארזרה 100 מ"ג ישראל - עברית - Ministry of Health

ארזרה 100 מ"ג

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

ווטריינט 200 מ"ג ישראל - עברית - Ministry of Health

ווטריינט 200 מ"ג

glaxo smith kline (israel) ltd - pazopanib as hydrochloride 200 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ווטריינט 400 מ"ג ישראל - עברית - Ministry of Health

ווטריינט 400 מ"ג

glaxo smith kline (israel) ltd - pazopanib as hydrochloride 400 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

היקמטין 0.25 מג ישראל - עברית - Ministry of Health

היקמטין 0.25 מג

novartis israel ltd - topotecan as hydrochloride - קפסולות ג'לטין קשיחות - topotecan as hydrochloride 0.25 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.

אימיטרקס זריקות ישראל - עברית - Ministry of Health

אימיטרקס זריקות

glaxo smith kline (israel) ltd - sumatriptan as succinate - תמיסה להזרקה - sumatriptan as succinate 6 mg / 0.5 ml - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aure, cluster headache. for the acute treatment of migraine attacks associated with women's menstrual cycle.

אימיטרקס טבליות 100 מג ישראל - עברית - Ministry of Health

אימיטרקס טבליות 100 מג

glaxo smith kline (israel) ltd - sumatriptan as succinate - טבליות מצופות פילם - sumatriptan as succinate 100 mg - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

אימיטרקס טבליות 50 מג ישראל - עברית - Ministry of Health

אימיטרקס טבליות 50 מג

glaxo smith kline (israel) ltd - sumatriptan as succinate - טבליות מצופות פילם - sumatriptan as succinate 50 mg - sumatriptan - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

אימיטרקס ספריי לאף 20 מג ישראל - עברית - Ministry of Health

אימיטרקס ספריי לאף 20 מג

glaxo smith kline (israel) ltd - sumatriptan - תמיסה - sumatriptan 20 mg / 0.1 ml - sumatriptan - sumatriptan - imitrex nasal spray is indicated for the acute treatment of migraine attacks with or without aura.

אימיטרקס אפ.די.טי 50 מ"ג ישראל - עברית - Ministry of Health

אימיטרקס אפ.די.טי 50 מ"ג

glaxo smith kline (israel) ltd - sumatriptan as succinate 50 mg - tablets fast disintegrating - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.